stronger than semaglutide We know about the growing popularity of and Tirzepatide for their positive weight loss outcomes. But how do these two treatments differ? Swipe to discover the key differences! Want to find Tirzepatide (MOUNJARO®/ZEPBOUND) vs Semaglutide (OZEMPIC®/WEGOVY®)
Description
Book it today.
The incidence of DS was reported between 9 to 42.9% and 0.5% to 27.8% in studies using the Sigstad dumping score and patients self-reported DS, respectively
Join our wellness clinic today
While the absolute risk increase was modest, our findings point to an important potential adverse effect that clinicians should consider, especially in patients with predisposing factors for GERD
For Research Use Only
